GlassScriptPhysician profile
Gary W Duncan
NPI 1043342678
$2,540.60
in general payments reported to CMS, 2019-2025
31 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $160 · 2021: $510 · 2022: $393 · 2023: $557 · 2024: $478 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,018 · Consulting Fee: $200 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,018.10 |
| Consulting Fee | $200.00 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $609.72 | 2019-2025 | Lo Loestrin Fe, Liletta |
| Pfizer INC. | $296.73 | 2019-2024 | |
| Millicent US INC | $204.97 | 2021-2025 | Intrarosa, Femlyv, Femring |
| Mimedx Group, INC. | $200.00 | 2024 | |
| Astellas Pharma US INC | $139.89 | 2023 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $131.03 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $129.47 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $97.91 | 2019-2022 | |
| Innovation Technologies INC | $81.05 | 2023 | Irrisept |
| Mayne Pharma Commercial LLC | $76.73 | 2022-2025 | |
| Baxter Healthcare | $50.96 | 2024-2025 | Perclot, Tisseel |
| Hologic Sales and Service, LLC | $49.31 | 2019-2024 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Evofem Biosciences, INC. | $46.06 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.80 | 2022-2023 | |
| Coopersurgical, INC. | $39.02 | 2020-2023 | Mara Console |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $34.80 | 2021-2025 | Slynd |
| Merck Sharp & Dohme LLC | $33.51 | 2020-2021 | |
| Avion Pharmaceuticals | $28.54 | 2022-2023 | Balcoltra |
| Exact Sciences Corporation | $27.63 | 2023-2024 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $22.84 | 2022 | |
| Meditrina | $21.53 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $21.14 | 2021 | |
| Virtus Pharmaceuticals LLC | $20.74 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $20.00 | 2023 | Vivjoa |
| Sage Therapeutics, LLC | $19.90 | 2024 | |
| Duchesnay USA Incorporated | $19.17 | 2019 | |
| Organon LLC | $17.99 | 2024 | |
| Ascend Therapeutics US, LLC | $16.56 | 2021 | |
| Minerva Surgical, INC | $13.85 | 2024 | |
| Allergan, INC. | $13.77 | 2019 | |
| Amag Pharmaceuticals, INC. | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.